Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
25
# OF OVERLAPPING
HOLDINGS
WDNA
85
HOLDINGS
32%
ALSO IN HELX
HELX
67
HOLDINGS
45%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus HELX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in HELX |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 2.9% | 6.9% | 2.9% |
|
ELI LILLY & CO | 3.1% | 2.7% | 2.7% |
|
UNITED THERAPEUTICS CORP | 2.3% | 3.4% | 2.3% |
 |
ASTRAZENECA PLC-SPONS ADR | 2.1% | 2.8% | 2.1% |
|
IONIS PHARMACEUTICALS, INC. | 2.2% | 2.0% | 2.0% |
WDNA Overweight Relative to HELX
|
JOHNSON & JOHNSON | 2.7% |
|
MODERNA, INC. | 2.6% |
|
PFIZER INC | 2.4% |
|
REGENXBIO, INC. | 2.3% |
|
AMGEN INC | 2.2% |
|
AMICUS THERAPEUTICS INC | 2.2% |
 |
NOVO NORDISK A/S-B | 2.2% |
|
NOVOZYMES A/S-B SHARES | 2.0% |
|
IMMUNOME, INC. | 1.9% |
|
GILEAD SCIENCES INC | 1.7% |
WDNA Underweight Relative to HELX
|
GUARDANT HEALTH, INC. | -6.8% |
|
MEDPACE HOLDINGS, INC. | -4.4% |
|
INSMED INC | -4.3% |
|
NATERA INC | -4.0% |
|
BRIDGEBIO PHARMA, INC. | -3.3% |
|
ADAPTIVE BIOTECHNOLOGIES CORP. | -3.3% |
|
ALNYLAM PHARMACEUTICALS INC | -3.1% |
|
KRYSTAL BIOTECH, INC. | -3.1% |
|
LIGAND PHARMACEUTICALS-CL B | -3.0% |
|
GENEDX HOLDINGS CORP. CLASS A | -2.3% |